The Europe home infusion therapy market is expected to grow from US$ 4,482.33 million in 2022 to US$ 7,281.99 million by 2028. It is estimated to grow at a CAGR of 8.4% from 2022 to 2028.
Reduction in Duration of Hospital Stays and Cost of Care is Driving Europe Home Infusion Therapy Market
Many times, patients need to stay in the hospital to complete their course of intravenous drug administrations before they are shifted to oral medications. However, with an effective home infusion service, these patients can be transitioned to home early. The hospital-at-home model delivers hospital-level care within the home environment to support improved outcomes and enhance the patient experience. Thus, the possibility to treat several complicated medical conditions with home infusion therapies help reduce the length of hospital stays, consequently reducing the cost of treatment.
Home infusion imparts significant cost-savings compared to a traditional hospital infusion setting. Infusion provided at home costs 50% less than infusion provided at hospital facilities. According to the article published by Beckers Hospital in 2020, the average cost of home infusion is US$ 140–250 per day while hospital infusions on average costs US$ 590 per patient per infusion. According to the Commonwealth Fund, hospital-at-home programs help to cut the cost of care by over 30%, doing remarkably well in countries with single-payer systems, such as England.
Patients requiring intravenous therapies in emergency departments can be shifted to home infusion after clinical assessment. The homecare plan includes robust clinical monitoring at home, which allows the early identification of further clinical problems and the implementation of treatment plans to avoid readmissions. An Option Care study of 124 home parenteral nutrition (HPN) and 126 home enteral nutrition (HEN) patients showed that home infusion prevents hospitalization and improves patient care. Both HPN and HEN therapies can be temporarily administered in hospitals, yet ~40,000 HPN patients and 344,000 HEN patients yearly receive their nutrition therapies at home. Therefore, a significant reduction in the cost of care with a decrease in the length of hospital stays, along with the increasing number of patients availing homecare services, fuel the home infusion therapy market growth.
Europe Home Infusion Therapy Market Overview
The European home infusion therapy market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the home infusion therapy market. The European home infusion therapy market is expected to witness significant growth during the forecast period due to factors such as the significant growth in elderly population, increasing incidences of cancer and diabetes cases, and the favourable government initiatives for the treatments in the region.
Europe Home Infusion Therapy Market Revenue and Forecast to 2028 (US$ Million)
Europe Home Infusion Therapy Market Segmentation
The Europe home infusion therapy market is segmented into product, application, route of administration and country.
Based on product, the home infusion therapy market is segmented into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The home infusion therapy market segment is sub segmented into insulin pumps, elastomeric pumps, syringe pumps, and others. The infusion pumps segment held the largest market share in 2022.
Based on application, the home infusion therapy market is segmented into enteral nutrition, anti-infective, endocrinology, hydration therapy, chemotherapy, specialty pharmaceuticals, and others. The anti-infective segment held the largest share of the market in 2022.
Based on route of administration, the home infusion therapy market is segmented into intramuscular, subcutaneously, and epidural. The intramuscular segment held the largest share of the market in 2022.
Based on country, the Europe home infusion therapy market is segmented into Germany, France, United Kingdom, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022.
B. Braun Melsungen AG; Micrel Medical Devices SA; Baxter International Inc; Nipro Corp; Becton Dickinson and Co; Fresenius Kabi AG; ICU Medical Inc; JMS Co Ltd; Eitan Medical Ltd; Terumo Corp are the leading companies operating in the Europe home infusion therapy market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 4,482.33 Million |
| Market Size by 2028 | US$ 7,281.99 Million |
| CAGR (2022 - 2028) | 8.4% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Home Infusion Therapy Market is valued at US$ 4,482.33 Million in 2022, it is projected to reach US$ 7,281.99 Million by 2028.
As per our report Europe Home Infusion Therapy Market, the market size is valued at US$ 4,482.33 Million in 2022, projecting it to reach US$ 7,281.99 Million by 2028. This translates to a CAGR of approximately 8.4% during the forecast period.
The Europe Home Infusion Therapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Home Infusion Therapy Market report:
The Europe Home Infusion Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Home Infusion Therapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Home Infusion Therapy Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Home Infusion Therapy Market
